Breaking Cancer News dives into how Vigilant Biosciences® is advancing the early detection of oral cancer with its BeVigilant™ OraFusion™ System. The article features insights from oral surgeon Dr. William Shepard, who shares how this biomarker-driven saliva test is changing how clinicians assess risk and decide when to escalate care. By combining clinical data with AI-driven analysis of protein markers, the system offers a more precise, non-invasive way to identify early cancerous changes—empowering dentists to take a more confident, proactive approach.
Read the full article here.
Breaking Down Biomarkers: How the BeVigilant™ OraFusion™ System is Redefining Early Oral Cancer Detection
EN 
IT 
DE 
TR 
PT 
NL 
FR 
ES